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Hyperinsulinemia has been shown to be
associated with diabetic angiopathy. Migration
and proliferation of vascular smooth muscle
cells (VSMC) are the processes required for the
development of atherosclerosis. In this study,
we attempted to determine whether insulin
affects mitogenic signaling induced by platelet-
derived growth factor (PDGF) in a rat VSMC
cell line (A10 cells). PDGF stimulated DNA
synthesis which was totally dependent on Ras,
because transfection of dominant negative Ras
resulted in complete loss of PDGF-stimulated
DNA synthesis. Initiation of DNA synthesis
was preceded by activation of Raf-1, MEK and
MAP kinases (Erk 1 and Erk2). Treatment of
the cells with PD98059, an inhibitor of MAPK
kinase (MEK) attenuated but did not abolish
PDGF-stimulated DNA synthesis, suggesting
that MAPK is required but not essential for
DNA synthesis. PDGF also stimulated phos-
phorylation of protein kinase B (Akt/PKB) and
p70 S6Kinase (p70S6K) in a wortmannin-sensi-
tive manner. Rapamycin, an inhibitor of
p70S6K, markedly suppressed DNA synthesis.
Low concentrations of insulin (1-10 nmol/l)
alone showed little mitogenic activity and no
significant effect on MAPK activity. However,
the presence of insulin enhanced both DNA
synthesis and MAPK activation by PDGF. The
enhancing effect of insulin was not seen in cells
treated with PD98059. Insulin was without
effect on PDGF-stimulated activations of pro-
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1560-4284/02 $12.00 + .00tein kinase B (Akt/PKB) and p70S6K. We con-
clude that insulin, at pathophysiologically rele-
vant concentrations, potentiates the PDGF-
stimulated DNA synthesis, at least in part, by
potentiating activation of the MAPK cascade.
These results are consistent with the notion
that hyperinsulinemia is a risk factor for the
development of atherosclerosis.
Key words: PDGF, insulin, MAPK, VSMC, ath-
erosclerosis
INTRODUCTION
Proliferation of vascular smooth muscle cells
(VSMC) is one factor responsible for the devel-
opment of atherosclerosis. A number of growth
factors, including platelet-derived growth fac-
tor (PDGF), epidermal growth factor (EGF),
fibroblast growth factor(FGF) and insulin-like
growth factors (IGFs), have been shown to
stimulate proliferation of VSMC in vivo or in
vitro [1-5]. PDGF appears to play a key role in
the development of diabetic angiopathy,
because it promotes not only proliferation, but
also chemotaxis and proteoglycan synthesis in
VMSC [6-8]. Earlier studies have also shown
endogenous hyperinsulinemia or prolonged
insulin administration to result in development
of atherosclerosis-like lesions (reviewed in [9,
10]), although insulin is a weak growth-mito-
gen. It is possible that insulin is permissive in
terms of mitogenic activity of other growth fac-
tors. Goalstone et al. recently reported that
insulin potentiates PDGF-stimulated DNA syn-
thesis in rat and porcine VSMC [11] by stimu-
lating the prenylation of p21 Ras, suggesting
that Ras-mediated mechanisms are involved in
the potentiating effect of insulin. However, the
mechanism by which insulin synergizes with
PDGF is not fullly understood. 
Both insulin and PDGF transmit signals
through binding to cognate receptors with
intrinsic tyrosine kinase activity, and they uti-
lize a number of common signaling pathways
[12,13] including the mitogen-activated protein
kinase (MAPK) cascade and phosphatidylinosi-
tol 3-kinase (PI3K). Activation of the classical
MAPK pathway is initiated by ligand-induced
activation of the receptor followed by sequen-
tial phosphorylation and activation of Ras,
Raf, MAPK kinase (MAPKK or MEK) and
MAPK (also known as Extracellular signal reg-
ulated kinase, Erk). Two isoforms of MAPK,
the p44 MAPK (Erk-1) and the p42 MAPK
(Erk-2) have been identified in most cells, and it
is well established that MAPK plays an impor-
tant role in regulating cell proliferation or dif-
ferentiation depending on cell types [14, 15]. 
PI3K is a heterodimer consisting of an 85-
kDa regulatory subunit and a 110kDa catalytic
subunit. The 85 regulatory subunit functions as
an adaptor which links PI3K to tyrosine phos-
phorylated proteins such as autophosphorylat-
ed PDGF receptors and tyrosine-phosphorylat-
ed insulin receptor substrate (IRS), and this
association stimulates the kinase activity of the
p110 subunit [16]. PI3K-mediated activation of
the downstream kinases such as protein kinase
B (PKB or Akt) and p70S6 kinase (p70S6K),
has been implicated in various cellular respons-
es including proliferation, differentiation, and
apoptosis [17, 18].
The goal of this study was to determine
whether insulin influences PDGF-stimulated
activation of the MAPK cascade and PI3K-
mediated signaling in rat VSMC (A10). We
demonstrate that physiological concentrations
of insulin, a weak mitogen on its own, signifi-
cantly enhances both DNA synthesis and acti-
vation of the MAPK cascade simulated by
PDGF without little effect on PI3K-mediated
signaling. The effect of insulin was abrogated
by blockade of the MAPK cascade, which is
consistent with the view that insulin effects are
mediated via enhancement of PDGF-stimulated
MAPK pathway.
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MATERIALS
Recombinant human PDGF (PDGF-BB)
was purchased from Upstate Biotechnology
(Lake Placid, NY). Porcine insulin was
obtained from Sigma Chemical (St. Louis,
MO), as were wortmannin, rapamycin and
manumycin A. PD098059 was purchased
from New England Biolabs (Berverly, MA).
Polyclonal antibody (αY91), prepared in rab-
bits, against the synthetic peptide containing
the triple tyrosine residues of Erk1 which rec-
ognize both Erk1 and Erk2 was provided by
Dr. T.Kadowaki (University of Tokyo) [19].
Antibodies to phosphorylated Erk, phospho-
rylated (Thr421/Ser424) p70S6 kinase, and
phosphorylated protein kinase B (PKB/Akt)
were purchased from New England Biolabs.
Antiphosphotyrosine antibody was obtained
from Transduction Laboratories (Lexington,
KY). [3H]thymidine (74.0GBq/ml) and
[γ32P]ATP (222 TBq/mmol) were purchased
from Dupont-New England Nuclear (Boston,
MA).
CELL CULTURE
A10 cells were obtained from American type
collection (ATCC) (Rockville, MD). This cell
line was derived form the thoracic aorta of
DBIX embryonic rats and possesses many of
the characteristics of VSMC [20]. The cells
were maintained in Dulbecco’s modified Eagles
medium (DMEM) supplemented with 10%
fetal calf serum (Nakarai Chemical, Tokyo) in
a humidified atmosphere of 95% air and 5%
C02. All experiments were performed with cells
from passages 5-20.
DNA SYNTHESIS
The cells were grown to subconfluence in
multiwell plastic plates. The medium was
removed and replaced with serum-free DMEM
supplemented with 0.1% bovine serum albu-
min (BSA). After 24h, the cells were exposed to
the indicated concentrations of insulin with or
without PDGF for 24h, in the presence of 1
µCi(7.4x104 Bq)/ml [3H]thymidine
(20Ci/mmol; New England Nuclear, Boston,
MA). Cultures were washed twice with ice-cold
phosphate-buffered saline (PBS) and precipitat-
ed with ice-cold 10% trichloroacetic acid
(TCA). DNA synthesis in the cells (per 105
cells) was determined by the extent of
[3H]thymidine incorporation into TCA-insolu-
ble fractions.
CELL PROCESSING
At the indicated period after stimulation, the
medium was removed and the cells washed
once with ice-cold PBS and scraped on ice into
lysis buffer (25 mmol/l Tris/HCl, pH 7.4, 25
mmol/l NaCl, 1 mmol/l sodium orthovanadate,
10 mmol/l NaF, 0.5 mmol/l EGTA, 10 mmol/l
sodium pyrophosphate, 10 nmol/l okadaic
acid, 1 mmol/ PMSF, 1% Triton-X). The sus-
pension was sonicated and the tubes were cen-
trifuged at 15,000 x g for 60min at 4˚C. The
resultant supernatant was used for measure-
ment of signaling components. The protein
concentration was determined with a Bio-Rad
Protein Assay kit (Bio-Rad Laboratories,
Richmond, CA). 
KINASE ASSAY
MAP kinase activity in cell extracts was
measured by the ability to phosphorylate
myelin basic protein (MBP). The procedure was
essentially as previously described [19]. The cell
extracts (200-400 µl) were incubated with
αY91 in the presence of 0.1% SDS for 2h on
ice, and 50 µl of a 50% (v/v) suspension of pro-
tein A-Sepharose were added and the incuba-
tion was continued for another for 3h at 4˚C.
The immunoprecipitated complex was washed
twice with buffer A containing 25 mmol/l Tris-
HCl (pH 7.4), 25 mmol/l NaCl, 1 mmol/l
EGTA, and 1 mmol/l sodium orthovanadate,
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phate and 10 nmol/l okadaic acid. The
immunoprecipitates were washed twice with
buffer A, and resuspended in 50 µl of kinase
buffer (25 mmol/l Tris-HCl , pH7.4, 10 mmol/l
MgCl2, 1 mmol/l dithiothreitol, 40 µmol/l ATP,
2 µCi of [γ-32P]ATP, 2 µmol/l cAMP dependent-
protein kinase inhibitory peptide, 0.5 mmol/l
EDTA) containing 25 µg MBP (Sigma, St Louis,
MO) and incubated at 25˚C for 15min. The
reaction was terminated by adding 15 µl of
stopping solution containing 0.6 mol/l HCl, 1
mmol/l ATP and 1% BSA. Aliquots (15 µl) of
the supernatants were spotted onto 1.5 x 1.5
cm squares of p81 (Whatman International,
Maidstone, UK), washed 5 times for 5min each
in 0.5% phosphoric acid, washed in acetone,
dried and counted using Cerenkov counting. In
some experiments, MAP kinase activity in
selected samples was measured using myelin
basic protein (MBP) containing polyacrylamide
gels (in gel assay) as previously described [21].
Twenty µl of the cell extract (protein 20µg) was
electrophoresed on SDS-polyacryalmide gel
containing 500 mg/l MBP. After the enzymes in
the gel had been denatured and then renatured,
the gel was incubated with 10 ml of 40 mmol/l
of Hepes, pH 8.0, containing 0.5 mmol/l
EGTA, 10 mmol/l MgCl2, 2 µmol/l protein
kinase inhibitor, 40 µmol/l ATP, and 25 µCi of
[γ-32P]ATP at 25 C for 1h. The gel was washed
with a 5% (w/v) trichloroacetic acid (TCA)
solution containing 1% sodium pyrophos-
phate, and phosphorylated MBP was identified
by autoradiography of the dried gel. Raf-1
kinase activity was determined using
gluthathione transferase (GST)-MEK as a sub-
strate [22]. GST-MEK had been bacterially pro-
duced and purified on glutathione-agarose
beads. Forty µl of cell extracts were incubated
for 30min at 25˚C in buffer B (25 mmol/l Tris-
HCl, pH 7.4, 10 mmol/l MgCl2, 30 mmol/l
DTT, 1mmol/l MnCl2, 1mmol/l EGTA) con-
taining 5 µCi [γ-32P-ATP] and GST-MEK (10
µg), and the mixture was incubated for 30min
at 25˚C. Then, 500 µl of a glutathione-
Sepharose 4B bead suspension (Pharmacia
Biotech, Uppsala, Sweden) in buffer A were
added to collect GST-MEK. After 30min on ice,
the Sepharose beads were washed once in
buffer B and then boiled for 3min in Laemmli
sample buffer, rapidly sedimented, and the
supernatant was then used for 8% SDS-PAGE.
Following electrophoresis, phosphorylated
GST-MEK was identified by autoradiography.
PI3K activity was measured on anti-phosphoty-
rosine immune complexes, essentially as
described previously [23]. The reactions were
initiated by the addition of 50 nmol/l ATP, 5
mmol/l MgCl2 and 2 µCi of [γ-32P] ATP and
stopped after 20 min at 30C with 10µl of 4
mol/l HCl and 250µl of chloroform/methanol
(1:1, v/v). The lower organic phase was washed
with 150 µl of methanol/1M HCl (1:1, v/v) and
dried. Phospholipids were resuspended in 10 ml
of chloroform, separated by TLC on alu-
minum-backed silica gel 60 plates pretreated
with 1% potassium oxaloate in the solvent sys-
tem chroroform/methanol/acetone/acetic acid
water (60:20:23:18:11; vol/vol), and the detec-
tion and quantification of [32P]-PI3P were
accomplished by autoradiography. 
WESTERN BLOT
The cell extract (20 µg protein) in Laemmli
sample buffer (62 mmol/l Tris-HCl buffer, pH
6.8, in the presence of 2.0% sodium dodecyl
sulfate, 10% glycerol, and 0.05% bromophe-
nol blue) was heated for 5min at 95˚C, and
resolved on 10% SDS-gel in the presence of a
reducing agent. The proteins were then trans-
ferred onto a nitrocellulose sheet (Japan Bio-
Rad, Tokyo) in transfer buffer (25 mmol/l Tris-
HCl/192 mmol/l glycine/20% methanol) with
Trans-Blot apparatus (Bio-Rad). Protein bind-
ing sites were blocked by incubating the sheets
for 1h with 5% skim milk powder in TTBS
buffer (20 mmol/l Tris-HCl, pH 7.5 /137
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sheets were washed three times and then incu-
bated overnight with antibodies to MAPK
(Erk), phosphospecific MEK, p70S6 Kinase
(P70S6K), or protein kinase B (PKB/Akt). The
immune-complex was visualized with an
enhanced chemiluminescence (ECL) system
(Amersham, Buckinghamshire, UK) according
to the manufacturer’s manual using Kodak
XAR film. The bands on the film were quanfied
densitometrically. 
ADENOVIRUS-MEDIATED GENE TRANSFER
The cDNA plasmid for dominant negative
Ras (Asn-17) was provided by Dr. T. Kadowaki
T (University of Tokyo). The recombinant ade-
noviruses AdexCALacZ and AdexCAdnRas
were constructed by homologous recombina-
tion between the expression cosmid cassette
and the parental viral genome, and adenovirus-
mediated gene transfer was carried out as pre-
viously described [24]. When the adenovirus
AdexCALacZ was applied at 3x107 PFU per
cm2 dish, LacZ was expressed in more than
90% of the cells 24h after transfection. We
applied this dose and control cells were trans-
fected with AdexCALacZ virus. An adenovirus
vector encoding a dominant negative mutant
Akt (AxCAAkt-AA) in which the phosphoryla-
tion sites (Thr308 and Ser473) were replaced
by alanine was kindly provided by Drs. M.
Kasuga and W. Ogawa (Kobe Univerisity). A10
cells were infected with the adenovirus vectors
as described [25]. The cells were used 24-48 h
after the transfection. 
STATISTICAL ANALYSIS
The differences between groups were deter-
mined by ANOVA (Fisher’s multiple compar-
isons test) using the STATView program
(Abacus, Berkeley, CA). Differences were con-
sidered significant when the p-value was less
than 0.05. The values presented are mean±SD
unless otherwise stated.  
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FIGURE 1
Synergism between insulin and PDGF in stimulating DNA synthesis. 
Left: Subconfluent A10 cells in serum-free medium were treated with the indicated concentrations of insulin without (❍) or with 250
pmol/l PDGF ( ). 
Right: The cells were treated with PDGF alone (❑) or in the presence of 1 nmol/l insulin ( ). After 16 h of incubation, [3H]-thymidine
incorporated into DNA was measured as described in the text. The values are means±SD of triplicate determinations from one repre-
sentative experiment out of three.RESULTS
SYNERGISM OF INSULIN AND PDGF 
IN MITOGENESIS
Insulin showed poor mitogenic activity in
A10 cells, and DNA synthesis was detected
only with insulin concentrations higher than
1.0 nmol/l. However, in the presence of 250
pmol/l PDGF, low concentrations of insulin
(0.1-1.0 nmol/l) dose-depedendently stimulated
DNA synthesis (Fig.1 left). Likewise, the pres-
ence of insulin (1.0 nmol/l) significantly poten-
tiated PDGF-stimulated DNA (Fig.1 right);
DNA synthesis induced by 50 pmol/l PDGF
increased by more than 3-fold in the presence
of insulin. 
The apparent synergism between insulin and
PDGF was not due to the difference in the time
course of DNA synthesis between cells stimu-
lated by PDGF alone versus those exposed to
PDGF plus insulin. In both cases, peak [3H]-
thymidine incorporation was obtained at 16-18
h after stimulation (Fig. 2). 
SIGNALING BY PDGF 
We first studied the signaling pathways
elicited by PDGF and their roles in DNA syn-
thesis in A10 cells. As shown in Fig.3, PDGF
phosphorylated and activated MAP kinases
(Erk1 and Erk2) within 5min and the peak
activity was generally seen at 10-20 min after
stimulation. The activity then decreased, fol-
lowed by a slight increase at 3-6 h. Generally,
the activity remained above basal levels for
more than 12h, which is similar to the result
reported for human VSMC [26]. As reported
for other types of cells, PDGF also stimulated
Akt and p70S6K phosphorylation in A10 cells?
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FIGURE 2 
Time course of DNA synthesis stimulated by PDGF in the presence or absence of insulin. 
A10 cells were incubated with 50 pmol/l of PDGF alone (❍), PDGF plus 1 nmol/l of insulin ( ), insulin alone ( ) or medium alone (❑)
for the indicated periods. [3H]-thymidine was added during the last 2 h. The values are means±SD of triplicate determinations. (Fig. 4). Phosphorylation of both kinases was
evident within 10min. In most studies, the
extent of Akt phosphorylation returned to
basal levels by 12 h, whereas that of p70S6K
remained above basal levels for longer periods. 
It has been shown that activations of both
Akt and p70S6K is, at least in part, PI3K-
dependent [16, 26]. Pretreatment of cells with
wortmannin (100 nmol/l), a PI3K inhibitor,
resulted in a significant decrease (32±6 % of
control cells; in 3 experiments) in PDGF-stimu-
lated PI3K activity (Fig. 5). Likewise, phospho-
rylations of Akt and p70S6K were significantly
attenuated by wortmannin.
In cells transfected with dnRas, PDGF-stim-
ulated PI3K activation decreased slightly, but
significantly (p<0.05), to 74±3 % of that in
control cells transfected with the vector alone
(LacZ) in 3 experiments. Phosphorylations of
Akt and p70S6K also tended to be decreased as
compared to those in control cells, but the dif-
ferences did not reach statistical significance. 
To ascertain the roles of the MAPK cascade
and PI3K-mediated signaling pathways in the
mitogenic activity of PDGF, the effects of sever-
al inhibitors of the MAPK cascade or PI3K-
mediated pathways on the PDGF-stimulated
DNA synthesis were studied, and the results
were correlated with the stimulated MAPK
activities (Fig. 6). Treatment of A10 cells with
PD98059 (30 µmol/l), a MEK inhibitor, almost
completely abolished PDGF-stimulated MAPK
activity, while decreasing DNA synthesis by
only 40±4 %. The potentiating effects of
insulin on PDGF-induced DNA synthesis and
MAPK activation were not seen in cells treated
with PD98059 (data not shown). 
In cells transfected with dominant negative
Ras (dnRas), both DNA synthesis and MAPK
activation by PDGF, in the presence or absence
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FIGURE 3 
Effect of PDGF on MAP kinase activation and phosphorylation.
The cells cultured in serum-free medium for 24 h were challenged with 50 pmol/l PDGF for the indicated periods. MAP kinase activi-
ty was determined by phosphorylation of MBP as described in the text (mean±SD of triplicate determinations). Western blots results
using antibodies to phosphorylated Erks are shown at the top (representative of four experiments). Arrows indicate phosphorylated Erk
1 (44KDa) and phosphorylated Erk 2 (42KDa).of insulin were almost completely abolished,
while the responses in cells transfected with the
vector alone were comparable to those in con-
trol cells. Similarly, treatment with manumycin
A, (10 mmol/l for 8h) an inhibitor of trans-
ferase, significantly inhibited both DNA syn-
thesis and MAPK activation, and the responses
to PDGF were not different from those to
PDGF plus insulin (data not shown).
Rapamycin (30 nmol/l), reportedly a specific
inhibitor of p70S6K, also potently inhibited
PDGF-stimulated mitogenic activity, but
showed no effects on PDGF-stimulated MAPK
activity. Treatment with wortmannin (100
nmol/l) significantly (p<0.01) inhibited MAPK
activity (70±4 % of control) and DNA synthe-
sis (56±3%). Transfection of dominant nega-
tive Akt (dnAkt) resulted in 30-50% decreases
in both basal PDGF-stimulated DNA synthesis
and MAPK activation, but the percent increas-
es (stimulated/basal) were not different from
those in cells transfected with the vector alone
(data not shown). Cells transfected with the
mutant Akt, however, easily detached from the
bottoms of dishes and died, most likely via
apoptosis.
EFFECT OF INSULIN ON PDGF-INDUCED
SIGNALING
We next studied whether insulin modifies the
signaling pathways stimulated by PDGF. The
effects of insulin, PDGF and insulin plus PDGF
on activation of Raf-1, which functions
upstream from MEK1 (MAPK kinase), and on
the downstream MAPK were evaluated (Fig. 7).
Although insulin at 1 nmol/l alone activated
neither Raf-1, nor MAPK, it significantly
(p<0.05) potentiated and sustained the activi-
tions of the kinases stimulated by PDGF (50
pmol/l). In contrast, there was no synergism
138 YAMADA, ET AL.
I NTERNATIONAL J OURNAL OF E XPERIMENTAL D IABETES R ESEARCH
FIGURE 4 
Effects of PDGF on phosphorylations of Akt and p70S6K
The cells were treated with PDGF (250 pmol/l) for 10min, and cell lysates were subjected to Western blot using antibodies against phos-
phorylated Akt or 70S6K. Representative Western blots are shown at the top. Results of densitometric analysis of Western blots in 4
experiments (open circle: pp70S6K, closed cicle: pAkt ) are shown in the botom panel (means±SD). MITOGENIC ACTIVITY OF PLATELET-DERIVED GROWTH FACTOR 139
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FIGURE 5 
Wortmannin-dependent phosphorylation of Akt and p70S6K
The cells were pretreated with (lane c) or without (lanes a, b) 100 nmol/l of wortmannin (WT). They were then stimulated with 250
pmol/l of PDGF for 15min. Cells transfected with dnRas were similarly stimulated with PDGF (lane d). The cell lysate was
immunopecipitated with antiphosphotyrosine antibody and PISK was determined as described in the text. A representative autoradi-
ograph, from one of 4 experiments, is shown in the top panel. In parallel experiments, phosphorylations of Akt and p70S6K were quan-
tified by Western blotting (middle and bottom panels). 
FIGURE 6 
Relation between PDGF-stimulated MAPK activity and DNA synthesis.
The cells were pretreated with or without (control) PD98059 (PD, 30 µM), wortmannin (WT, 100 nmol/l), or rapamycin (rapa, 30
nmol/l) for 30min ,or with manumycin (manu, 10 µmol/l) for 8h, before stimulation with 250 pmol/l PDGF. The cells transfected with
dnRas were also tested for the ability to respond to PDGF. DNA synthesis was measured as in Fig. 1. MAPK activity was measured by
immune complex kinase assay in cells stimulated with PDGF for 10min. The results shown are the mean±SD (horizontal bar) of four
experiments. Open and hatched columns represent the basal and post-PDGF stimulated values, respectively. The values are significant-
ly (a, p<0.01; b, p<0.05) lower than those in non-pretreated control cells.between insulin and PDGF in the abilities to
stimulate PI3K-dependent pathways (Fig. 8);
low concentrations of insulin only minimally
stimulated phosphorylations of PKB/Akt and
p70S6K, and did not influence the PDGF-stim-
ulated phosphorylations at any time point. In
selected samples, kinase activities of p70S6K
stimulated PDGF alone and those of PDGF
plus insulin were measured using synthetic S6
peptide as a substrate [27]. PDGF alone stimu-
lated activation of p70S6K by 5.6±0.3 fold at
10min, and by 5.5±0.2 fold at 30min, respec-
tively in three experiments. The values were
comparable to those in cells stimulated by
PDGF in the presence of 1.0 nmol/l insulin
(4.6±1.5 fold at 10 min, and 4.4±0.5 fold at 30
min). 
DISCUSSION 
The data presented herein show that physio-
logical concentrations of insulin (0.1-1 nmol/)
have little mitogenic activity alone while poten-
tiating PDGF-induced DNA synthesis in A10
cells. Our goal was to determine how insulin
potentiates the mitogenic effect of PDGF. To
address this question, we first studied which
signaling pathways are involved in DNA syn-
thesis stimulated by PDGF. Consistent with a
previous report [28], PDGF-stimulated DNA
synthesis and MAPK activation were signifi-
cantly reduced by transfection with dnRas.
Furthermore, manumycin A which inhibits far-
nesylaion of Ras, attenuated the responses.
Signaling pathways mediated by Ras are quite
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FIGURE 7 
Effect of insulin on PDGF-induced MAPK activation
A10 cells were stimulated with 1nmol/l insulin alone (❏), 250 pmol/l/ PDGF alone (❍) or insulin plus PDGF ( ) for the indicated peri-
ods. Raf-1 activity was measured as the extent of phosphorylation of GST-MEK. MAPK activity was determined by kinase assay using
MBP as a substrate. Data are expressed as means±SD of triplicate determinations. Activities of both MAPK and Raf-1 stimulated by
PDGF plus insulin were significantly (p<0.05) higher than those stimulated by PDGF alone. Autoradiographs of GST-MEK (left) and
MBP (right) in gel (in gel assay; as described in Materials and Methods).diverse [29], but loss of mitogenic responses to
PDGF in cells transfected with dnRas may be
accounted for, at least in part, by failure of the
cells to activate the MAPK cascade. Supporting
this, treatment of A10 cells with PD98059, an
inhibitor of MEK significantly attenuated
PDGF-induced DNA synthesis. Furthermore,
Robinson et al have reported that treatment of
rat aortic smooth muscle cells with antisense
oligonucleotides directed against MAPK almost
completely blocked PDGF-stimulated DNA
synthesis [30]. However, the inhibition of DNA
synthesis by PD98059 in A10 cells was not
complete at the concentration that completely
abolished PDGF-induced MAPK activation in
these cells. Thus, MAPK activation is required
but not sufficient for full mitogenic activity of
PDGF. 
We also showed PDGF-stimulated MAPK
activation to be partly inhibited by wortman-
nin, an inhibitor of PI3K. Reports on the effect
of wortmannin on MAPK activation are incon-
sistent, depending on cell type, or ligand [31].
The mechanism of MAPK inhibition by wort-
mannin is not clear at present, but grb2 or PKC
family members downstream from PLCγ may
be involved [31, 32]. 
PDGF also stimulated phosphorylations of
p70S6K and Akt in a wortmannin-sensitive
manner, as reported for several cell types. The
potent inhibition of DNA synthesis by
rapamycin suggests that p70S6K plays an
important role in mitogenesis during progres-
sion through the G1 phase of the cell cycle [33].
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FIGURE 8 
Effects of insulin on PDGF-induced Akt and p70S6K phosphorylations.
Upper panel: The cells were treated as in Fig.7. Phosphorylated PKB/Akt (right) and p70S6K (left) were determined by Western blot-
ting as in Fig. 4. Western blots shown at the top are representative of 4 experiments. 
Lower panel: Fold increases (stimulated/basal) in phosphorylations of p70S6K (left) and PKB/Akt (right) in the cells stimulated with
PDGF (P: 250 pmol/l), insulin (I:1 nmol/l) or PDGF plus insulin (P+I) for 20min were quantified densitometryically and are shown at
the bottom (the means±SD of three experiments). There were no significant differences in phosphorylations of either p70S6K or Akt in
the cells stimulated with PDGF alone versus those stimulated with PDGF plus insulin for 6 h (data not shown). The activation of p70S6K by PI3K is indirect,
and nonclassical protein kinase C (nPKC) or
Akt activated by PI3K, may be involved [18].
Furthermore, classical protein kinase C (cPKC),
produced by phospholipase C-γ (PLC-γ) or
TPA, is able to activate p70S6K [27, 34]. The
role of Akt in the mitogenic response to PDGF
appars to be minor, because transfection with
dominant negative Akt did not have significant
effects on DNA synthesis although the trans-
fection did accelerate cell death. Taken togeth-
er, these results indicate that both the MAPK
cascade and p70S6K are involved in PDGF-
stimulated DNA synthesis in A10 cells. 
We next studied how insulin affects these sig-
naling pathways and thereby enhances DNA
synthesis induced by PDGF. Low concentra-
tions of insulin enhanced PDGF-stimulated
MAPK, but not Akt or p70S6K activation. The
results suggest that the potentiating effects of
insulin on DNA synthesis are largely mediated
via MAPK pathway. This is supported by the
observation that the synergistic effect of insulin
was not seen when the cells were pretreated
with PD98059 or manumycin. In separate
experiments, insulin also enhanced both EGF-
stimulated DNA synthesis and MAPK activa-
tion (data not shown), and the potentiating
effect of insulin was not specific to PDGF. 
The enhancing effect of insulin was also seen
in PDGF-stimulated Raf-1 activation. Raf-1 is a
serine/threonine kinase which functions
upstream from MAPKK (MEK) and is activat-
ed by interacting with activated Ras (Ras-
GTP), and farnesylation of Ras is required to
for its translocation to the plasma membrane
and subsequent activation [34]. Insulin has
been shown to increase the amount of farnesy-
lated Ras via promoting activation of farnesyl-
transferase, and thereby augments the pool of
cellular Ras available for activation by growth
factors [11, 35]. Since Ras is a key upstream
factor controlling Raf-1 activity, ,increased
availability of Ras may potentiate PDGF-stim-
ulated sequential activation of Raf-1, MEK and
MAPK and thererby DNA synthesis. The lack
of an insulin effect on PDGF-stimulated Akt or
p70S6K could be explained by activation of
these kinases without requiring Ras; transfec-
tion of dnRas had a minimal effect on PDGF-
stimulated activation of these kinases.
In conclusion, insulin, at pathophysiological-
ly relevant concentrations, potentiates PDGF-
stimulated activation of the mitogenic response
in A10 cells. The potentiating effect of insulin
occurs, at least in part, via enhanced activation
of the MAPK cascade. These results support
the view that endogenous hyperinsulinemia
may accelerate proliferation of VSMC and
thereby the development of atherosclerosis.
Inhibitors of MAPK activation are potential
therapeutic agents which may retard the pro-
gression of atherosclerosis in hyperinsulinemic
patients.
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